Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zielasek

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Life Sciences|January 1, 1992
Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin modelJ Zielasek, H Kolb
Advances in Neuroimmunology|January 1, 1996
Molecular mechanisms of microglial activationJ Zielasek, H P Hartung
Annals of the New York Academy of Sciences|December 10, 1999
Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathiesJ Zielasek, K V Toyka
Der Nervenarzt|July 27, 2016
[Utilization of outpatient psychotherapeutic treatment : A secondary data analysis]W Gaebel, J Zielasek, S Kowitz
Immunitat Und Infektion|April 1, 1990
[Interleukin-2 modifies the development of insulin-dependent diabetes of BB rats]J Zielasek, V Burkart, H Kolb
Deutsche Medizinische Wochenschrift (1946)|May 29, 2014
[Mental healthcare in Germany--current situation and perspectives]S Kowitz, J Zielasek, W Gaebel
Neurochemistry International|July 1, 1996
Inhibition of cytokine-inducible nitric oxide synthase in rat microglia and murine macrophages by methyl-2,5-dihydroxycinnamateJ Zielasek, B Müller, H P Hartung
Current Opinion in Neurology|December 16, 1998
Inherited demyelinating neuropathies: from gene to diseaseR Martini, J Zielasek, K V Toyka
Muscle & Nerve|August 1, 1996
Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutationsJ Zielasek, R Martini, K V Toyka
Muscle & Nerve|May 8, 2000
Neuromyotonia in mice with hereditary myelinopathiesJ Zielasek, R Martini, U Suter, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Life Sciences|January 1, 1992
Ganglioside therapy of type I diabetes: enhancement of hyperglycemia in the low dose streptozotocin modelJ Zielasek, H Kolb
Advances in Neuroimmunology|January 1, 1996
Molecular mechanisms of microglial activationJ Zielasek, H P Hartung
Annals of the New York Academy of Sciences|December 10, 1999
Nerve conduction abnormalities and neuromyotonia in genetically engineered mouse models of human hereditary neuropathiesJ Zielasek, K V Toyka
Der Nervenarzt|July 27, 2016
[Utilization of outpatient psychotherapeutic treatment : A secondary data analysis]W Gaebel, J Zielasek, S Kowitz
Immunitat Und Infektion|April 1, 1990
[Interleukin-2 modifies the development of insulin-dependent diabetes of BB rats]J Zielasek, V Burkart, H Kolb
Deutsche Medizinische Wochenschrift (1946)|May 29, 2014
[Mental healthcare in Germany--current situation and perspectives]S Kowitz, J Zielasek, W Gaebel
Neurochemistry International|July 1, 1996
Inhibition of cytokine-inducible nitric oxide synthase in rat microglia and murine macrophages by methyl-2,5-dihydroxycinnamateJ Zielasek, B Müller, H P Hartung
Current Opinion in Neurology|December 16, 1998
Inherited demyelinating neuropathies: from gene to diseaseR Martini, J Zielasek, K V Toyka
Muscle & Nerve|August 1, 1996
Functional abnormalities in P0-deficient mice resemble human hereditary neuropathies linked to P0 gene mutationsJ Zielasek, R Martini, K V Toyka
Muscle & Nerve|May 8, 2000
Neuromyotonia in mice with hereditary myelinopathiesJ Zielasek, R Martini, U Suter, et al.
Pageof 7